252io

serious technical damage, momentum death cross on the way

Short
NYSE:VRX   None
vrx
Drug price committee may hurt growth immediate strategy

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.